Join to view full profile
2102 Harrisburg PikeLancaster, PA 17601
Phone+1 717-544-9400
Fax+1 717-544-9401
Dr. Abdulkareem is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Abdullateef Abdulkareem is an oncologist based in Lancaster, PA, specializing in hematologic oncology. He completed his fellowship in Hematology and Medical Oncology at Sidney Kimmel Medical College at Thomas Jefferson University and his residency in Internal Medicine at Tower Health. He earned his medical degree from Obafemi Awolowo University College of Health Sciences. Dr. Abdulkareem currently works as a Hematologist/Oncologist at Penn Medicine Lancaster General Health and previously served as a hospitalist at Upper Chesapeake Medical Services. His research includes a number of published works focusing on topics like lymphoproliferative disorders, radon exposure, and mesenteric carcinoid tumors, with some receiving citations in other academic publications.
Education & Training
Penn State Milton S Hershey Medical CenterResidency, Gastroenterology, 2020 - 2026
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 2019 - 2022
Tower HealthResidency, Internal Medicine, 2015 - 2018
Obafemi Awolowo University College of Health SciencesClass of 2005
Certifications & Licensure
PA State Medical License 2015 - 2026
MD State Medical License 2018 - 2020
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 4 citationsAntibody Response to SARS-CoV-2 Vaccination in Patients With Lymphoproliferative Disorders and Plasma Cell Dyscrasias: Anti-Lymphoma Therapy as a Predictive Biomarker ...Carol Gung, Regina McGuire, Mercy George, Abdullateef Abdulkareem, Katherine A Belden
Frontiers in Oncology. 2022-01-01 - 2 citationsRADON-222 ASSESSMENT AND ESTIMATION OF ANNUAL EFFECTIVE DOSE IN GROUNDWATER IN LAGOS STATE, NIGERIA.J. A. Ademola, Abdullateef Abdulkareem
Radiation Protection Dosimetry. 2019-12-31 - 5 citationsPrimary Mesenteric Carcinoid Tumor Presenting with Carcinoid Syndrome.Oluwaseun Shogbesan, Abdullateef Abdulkareem, Binu Pappachen, John Altomare
Case Reports in Gastroenterology. 2018-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
